Monopar Therapeutics Stock Price History
| MNPR Stock | USD 35.99 4.26 10.58% |
Below is the normalized historical share price chart for Monopar Therapeutics extending back to December 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Monopar Therapeutics stands at 35.99, as last reported on the 26th of February, with the highest price reaching 40.63 and the lowest price hitting 35.26 during the day.
If you're considering investing in Monopar Stock, it is important to understand the factors that can impact its price. Monopar Therapeutics is somewhat reliable given 3 months investment horizon. Monopar Therapeutics has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14 % return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.15% are justified by taking the suggested risk. Use Monopar Therapeutics Risk Adjusted Performance of 0.1351, mean deviation of 5.81, and Downside Deviation of 8.34 to evaluate company specific risk that cannot be diversified away.
At this time, Monopar Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 02/26/2025, Liabilities And Stockholders Equity is likely to grow to about 12.6 M, while Common Stock Shares Outstanding is likely to drop slightly above 12.7 M. . As of 02/26/2025, Price Earnings To Growth Ratio is likely to grow to 0.09, while Price Earnings Ratio is likely to drop (2.77). Monopar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of December 2019 | 200 Day MA 13.6636 | 50 Day MA 33.713 | Beta 1.315 |
Monopar |
Sharpe Ratio = 0.1385
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MNPR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.33 actual daily | 74 74% of assets are less volatile |
Expected Return
| 1.15 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Monopar Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Monopar Therapeutics by adding it to a well-diversified portfolio.
Monopar Therapeutics Stock Price History Chart
There are several ways to analyze Monopar Stock price data. The simplest method is using a basic Monopar candlestick price chart, which shows Monopar Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 10, 2025 | 51.89 |
| Lowest Price | November 25, 2024 | 19.4 |
Monopar Therapeutics February 26, 2025 Stock Price Synopsis
Various analyses of Monopar Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Monopar Stock. It can be used to describe the percentage change in the price of Monopar Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Monopar Stock.| Monopar Therapeutics Price Action Indicator | (4.08) | |
| Monopar Therapeutics Price Rate Of Daily Change | 0.89 | |
| Monopar Therapeutics Price Daily Balance Of Power | (0.79) |
Monopar Therapeutics February 26, 2025 Stock Price Analysis
Monopar Stock Price History Data
The price series of Monopar Therapeutics for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 33.8 with a coefficient of variation of 33.66. The daily prices for the period are spread out with arithmetic mean of 30.56. The median price for the last 90 days is 25.38. The company underwent 1:5 stock split on 13th of August 2024.| Open | High | Low | Close | Volume | ||
02/26/2025 | 40.63 | 40.63 | 35.26 | 35.99 | ||
| 02/24/2025 | 40.63 | 40.63 | 35.26 | 35.99 | 47,439 | |
| 02/21/2025 | 40.36 | 44.16 | 38.98 | 40.25 | 45,454 | |
| 02/20/2025 | 44.39 | 45.60 | 38.80 | 40.97 | 57,000 | |
| 02/19/2025 | 43.68 | 44.39 | 40.18 | 44.39 | 35,900 | |
| 02/18/2025 | 42.67 | 44.12 | 41.02 | 44.12 | 28,337 | |
| 02/14/2025 | 43.00 | 43.60 | 39.72 | 43.10 | 57,487 | |
| 02/13/2025 | 50.38 | 50.38 | 43.97 | 44.68 | 58,501 | |
| 02/12/2025 | 51.21 | 51.80 | 49.05 | 50.52 | 60,900 | |
| 02/11/2025 | 52.00 | 52.25 | 48.43 | 51.33 | 53,704 | |
| 02/10/2025 | 48.50 | 54.30 | 47.81 | 51.89 | 103,100 | |
| 02/07/2025 | 46.85 | 49.22 | 46.19 | 48.46 | 59,393 | |
| 02/06/2025 | 48.81 | 51.22 | 43.44 | 47.11 | 81,001 | |
| 02/05/2025 | 48.93 | 51.48 | 45.95 | 48.77 | 72,495 | |
| 02/04/2025 | 43.50 | 49.98 | 41.83 | 48.00 | 80,300 | |
| 02/03/2025 | 41.45 | 44.36 | 38.90 | 43.55 | 80,100 | |
| 01/31/2025 | 42.93 | 44.86 | 38.90 | 43.94 | 96,600 | |
| 01/30/2025 | 39.50 | 42.50 | 37.20 | 42.50 | 73,300 | |
| 01/29/2025 | 42.02 | 42.02 | 34.41 | 38.80 | 88,900 | |
| 01/28/2025 | 34.80 | 42.39 | 34.50 | 41.82 | 60,400 | |
| 01/27/2025 | 40.55 | 45.27 | 31.00 | 33.52 | 100,600 | |
| 01/24/2025 | 39.05 | 41.94 | 37.83 | 41.46 | 122,000 | |
| 01/23/2025 | 33.99 | 39.99 | 33.50 | 39.32 | 102,450 | |
| 01/22/2025 | 33.76 | 35.00 | 31.95 | 33.67 | 76,576 | |
| 01/21/2025 | 28.60 | 32.52 | 28.60 | 31.68 | 31,033 | |
| 01/17/2025 | 31.30 | 31.95 | 26.67 | 28.54 | 68,472 | |
| 01/16/2025 | 26.58 | 31.94 | 26.25 | 30.48 | 64,079 | |
| 01/15/2025 | 24.63 | 26.91 | 24.00 | 26.91 | 104,218 | |
| 01/14/2025 | 25.57 | 26.00 | 24.31 | 24.98 | 54,086 | |
| 01/13/2025 | 25.90 | 26.00 | 25.15 | 25.69 | 37,250 | |
| 01/10/2025 | 26.52 | 26.52 | 24.30 | 25.35 | 38,855 | |
| 01/08/2025 | 25.00 | 25.00 | 23.87 | 24.46 | 52,440 | |
| 01/07/2025 | 23.68 | 25.40 | 23.00 | 25.16 | 18,240 | |
| 01/06/2025 | 23.73 | 24.00 | 22.50 | 23.60 | 58,845 | |
| 01/03/2025 | 21.01 | 23.42 | 21.00 | 22.98 | 33,600 | |
| 01/02/2025 | 22.00 | 23.00 | 21.81 | 22.22 | 18,450 | |
| 12/31/2024 | 23.78 | 24.98 | 21.89 | 22.00 | 19,996 | |
| 12/30/2024 | 24.74 | 25.00 | 22.68 | 23.85 | 57,856 | |
| 12/27/2024 | 24.99 | 25.50 | 24.27 | 24.53 | 89,759 | |
| 12/26/2024 | 23.00 | 25.93 | 21.75 | 25.34 | 94,996 | |
| 12/24/2024 | 23.70 | 24.88 | 22.05 | 22.05 | 21,592 | |
| 12/23/2024 | 25.40 | 27.11 | 23.04 | 24.00 | 26,505 | |
| 12/20/2024 | 30.40 | 30.40 | 23.67 | 25.82 | 139,076 | |
| 12/19/2024 | 29.23 | 29.52 | 22.61 | 23.79 | 130,567 | |
| 12/18/2024 | 30.68 | 32.20 | 29.60 | 29.94 | 58,789 | |
| 12/17/2024 | 26.84 | 31.96 | 26.00 | 30.68 | 110,142 | |
| 12/16/2024 | 25.37 | 27.37 | 25.00 | 26.70 | 57,902 | |
| 12/13/2024 | 23.98 | 25.69 | 23.98 | 25.38 | 47,461 | |
| 12/12/2024 | 24.25 | 24.79 | 23.65 | 24.25 | 51,155 | |
| 12/11/2024 | 23.82 | 24.60 | 22.78 | 24.25 | 59,662 | |
| 12/10/2024 | 21.49 | 24.50 | 21.28 | 22.86 | 106,547 | |
| 12/09/2024 | 22.10 | 22.92 | 21.00 | 22.28 | 89,808 | |
| 12/06/2024 | 23.27 | 23.28 | 20.61 | 21.50 | 156,769 | |
| 12/05/2024 | 24.43 | 25.10 | 20.16 | 21.00 | 151,286 | |
| 12/04/2024 | 23.06 | 25.97 | 23.06 | 24.66 | 216,357 | |
| 12/03/2024 | 21.81 | 23.63 | 21.45 | 23.17 | 175,236 | |
| 12/02/2024 | 22.30 | 22.50 | 20.16 | 22.01 | 55,697 | |
| 11/29/2024 | 20.04 | 23.00 | 19.87 | 22.53 | 91,009 | |
| 11/27/2024 | 19.10 | 21.00 | 18.81 | 20.70 | 90,794 | |
| 11/26/2024 | 18.86 | 19.75 | 18.80 | 19.45 | 114,826 | |
| 11/25/2024 | 20.30 | 20.63 | 18.67 | 19.40 | 88,808 |
About Monopar Therapeutics Stock history
Monopar Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Monopar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Monopar Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Monopar Therapeutics stock prices may prove useful in developing a viable investing in Monopar Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 16.7 M | 12.7 M | |
| Net Loss | -8.2 M | -8.6 M |
Monopar Therapeutics Quarterly Net Working Capital |
|
Monopar Therapeutics Stock Technical Analysis
Monopar Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Monopar Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Monopar Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Monopar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Monopar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1351 | |||
| Jensen Alpha | 1.35 | |||
| Total Risk Alpha | 1.29 | |||
| Sortino Ratio | 0.1609 | |||
| Treynor Ratio | (13.84) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Monopar Stock Analysis
When running Monopar Therapeutics' price analysis, check to measure Monopar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monopar Therapeutics is operating at the current time. Most of Monopar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Monopar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monopar Therapeutics' price. Additionally, you may evaluate how the addition of Monopar Therapeutics to your portfolios can decrease your overall portfolio volatility.